• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Jim Stommen

Articles by Jim Stommen

Agile Therapeutics CEO says he's 'all in' on innovation

March 28, 2011
By Jim Stommen

Akron planning for seed fund to lure biomedical companies

March 28, 2011
By Jim Stommen
Turnabout is fair play, reasons the city of Akron, Ohio. Miami successfully lured Akron's native son, LeBron James, to leave the Cleveland Cavaliers and come play for the Florida city's NBA team, the Heat. Now Akron is eyeing a similar ploy, albeit one that will generate far less publicity. (Medical Device Daily)
Read More

Superior capabilities boost hybrid imaging, says report

March 25, 2011
By Jim Stommen
In a new report issued this week, global consulting firm Frost & Sullivan (F&S; Mountain View, California) says that hybrid imaging systems such as PET/CT and SPECT/CT are on the rise and have gained widespread recognition among the medical oncology community. (Medical Device Daily)
Read More

IOM offers clinical standards, effectiveness review guidance

March 24, 2011
By Jim Stommen
Tackling two topics on which there has been much discussion in recent years, the Institute of Medicine (IOM; Washington) has issued recommendations for standards in developing clinical practice guidelines and for systematic review of the comparative effectiveness in medical or surgical procedures. (Medical Device Daily)
Read More

Deals roundup: Quest continues acquisition push with deal to add Celera

March 21, 2011
By Jim Stommen
Continuing its push to grow through acquisitions, global diagnostic testing leader Quest Diagnostics (Madison, New Jersey) said Friday that it would add Celera (Alameda, California), a pioneering genetic diagnostics firm, in a merger deal valued at just over $670 million. (Medical Device Daily)
Read More

ASU researchers eye the use of tears for checking glucose

March 18, 2011
By Jim Stommen

EndoLumina eyes wireless sensing of upper GI bleeding

March 17, 2011
By Jim Stommen

Start-up firm mc10 aiming at combined mapping, ablation

March 15, 2011
By Jim Stommen
A Cambridge, Massachusetts-based start-up company, mc10, is focused on doing more with less, developing "smart" balloons that can eliminate one of the several catheters currently used in cardiac mapping and ablation procedures. (Medical Device Daily)
Read More

Hospital execs expect reform moves to spur their spending

Feb. 21, 2011
By Jim Stommen
The good news in L.E.K. Consulting's newly issued report on the spending plans of U.S. hospitals is that spending on medical equipment, spurred by healthcare reform, is expected to increase substantially. (Medical Device Daily)
Read More

Chris Rivera: President of Washington state life sciences association sees local gains from having a global health perspective

Feb. 1, 2011
By Jim Stommen
Previous 1 2 … 9 10 11 12 13 14 15 16 17 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 27, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 27, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • 3d rendering of bispecific antibodies

    Pfizer bets $6B+ on 3Sbio’s bispecific PD-1/VEGF antibody

    BioWorld
    Pfizer Inc. is paying $1.25 billion up front and up to $4.8 billion in milestone payments to gain global, ex-China rights to SSGJ-707, a PD-1/VEGF bispecific...
  • Illustration of liver with DNA double helixes

    ASGCT 2025: Gene and cell therapies transform metabolic diseases

    BioWorld Science
    Metabolic disorders such as argininosuccinic and glutaric aciduria, methylmalonic acidemia, homocystinuria or primary hyperoxaluria require specific diets to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe